Results 271 to 280 of about 359,341 (361)

Author's Reply: Refining Open-World Game and Nostalgic Film Interventions for Broader and More Reliable Therapeutic Impact.

JMIR Serious Games
Eisingerich AB, Arigayota A, Duffek B, Hou C.   +3 more
europepmc   +1 more source

Results from Reindl <i>et al</i>. (2025) support rather than challenge the sequence hypothesis. [PDF]

R Soc Open Sci
Lind J, Wartel A, Jon-And A, Ekström A, Vinken V, Enquist M.   +5 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Correction: Multiple social factors are associated with wellbeing when accounting for shared genetic and environmental confounding. [PDF]

Qual Life Res
Bjørndal LD, Nes RB, Ayorech Z, Vassend O, Røysamb E.   +4 more
europepmc   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Mert Sisman, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier   +9 more
wiley   +1 more source

Hashimoto's thyroiditis and hypothyroidism, treated with ShamanaChikitsa principles of Panduroga - A case report. [PDF]

J Ayurveda Integr Med
Anand PKV, Deshpande V.
europepmc   +1 more source

UNH Hosts Classics Scholar Oct 26 [PDF]

, 2005
Mantz, Erika
core   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Sant'Andrea della valle dataset: Georeferenced 2D study models of a Theatine Church. [PDF]

Data Brief
Bianchini C, De Stefano F, Giuliani G, Griffo M, Porfiri F.   +4 more
europepmc   +1 more source

Reseña del libro de Richard Hunter, Apollonius of Rhodes: Argonautica Book IV, Cambridge Greek and Latin Classics, Cambridge: Cambridge University Press, 2015, xi + 339 pp., ISBN 978-1-107-63675-0

, 2016
James L. Clauss
openalex   +1 more source